JIC
GHDX

Joel Isaacson & Co’s Genomic Health, Inc. GHDX Stock Holding History

Joel Isaacson & Co’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-200
Closed -$5K – 635
2014
Q2 		$5K Hold
200
– – ﹤0.01% 505
2014
Q1 		$5K Hold
200
– – ﹤0.01% 502
2013
Q4 		$6K Hold
200
– – ﹤0.01% 455
2013
Q3 		$6K Hold
200
– – ﹤0.01% 439
2013
Q2 		$6K Buy
+200
New +$6.57K ﹤0.01% 408

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Joel Isaacson & Co's GHDX Position: Q3 2014 in Review

Joel Isaacson & Co sold out of Genomic Health, Inc. (GHDX) in Q3 2014, closing a stake of 200 shares — an estimated $5K sold.

Joel Isaacson & Co first reported a position in GHDX in Q2 2013 and held it in 5 quarters. The position peaked at $6K in Q4 2013. 107 funds tracked by Wall St. Rank hold GHDX as of Q3 2014.

  • Joel Isaacson & Co reported no remaining Genomic Health, Inc. position as of Q3 2014 after selling out during the quarter.
  • Joel Isaacson & Co sold 200 Genomic Health, Inc. shares in Q3 2014, an estimated $5K.
  • Joel Isaacson & Co first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 5 quarters.
  • Joel Isaacson & Co's Genomic Health, Inc. position peaked at $6K in Q4 2013.
  • 107 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2014.

Based on Joel Isaacson & Co's 13F filing for Q3 2014, filed 22 Oct 2014.